Swedish Orphan Biovitrum AB (publ) reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was SEK 5,442 million compared to SEK 4,872 million a year ago. Net income was SEK 224 million compared to SEK 222 million a year ago.
For the six months, sales was SEK 11,698 million compared to SEK 10,111 million a year ago. Net income was SEK 1,024 million compared to SEK 1,288 million a year ago.